PCTY · Paylocity Holding Corporation

Current Thesis

Paylocity's earnings-led valuation recovery depends on regaining the August closing level of $157.93 while preserving its fiscal 2027 recurring-revenue guidance; a weekly close below $140 invalidates that recovery case. The 2026-09-11 adjusted close of $141.66 leaves the shares below the $147 post-earnings shelf identified in the 2026-08-30 research. The earlier finding that higher closes supported the advance no longer describes the supplied price evidence.

The narrative is maturing — the August earnings story remains the frame, but Argus published a quantitative-report target increase to $172 on 2026-09-02 followed by a reduction to $158 on 2026-09-09. Those reports document changing third-party valuation marks, not a company guidance revision. The forecast carries low conviction because the latest close has lost the intermediate shelf while the November revenue test remains ahead. Argus September 2 report, Argus September 9 report.

Bullish and bearish views on Paylocity Holding Corporation

The model's bull view on Paylocity Holding Corporation (PCTY), in brief: Recurring revenue supports the earnings story. The bear view: Guidance embeds slower recurring growth. Both cases follow in full.

Bull Case

• Recurring revenue supports the earnings story. Paylocity reported fourth-quarter fiscal 2026 recurring and other revenue of $415.6 million, up 12.4% year over year, on 2026-08-04. That is measured operating growth supporting the recovery thesis. Company results.
• The next revenue test is explicit. The 2026-08-04 outlook set first-quarter fiscal 2027 recurring and other revenue at $414.0 million–$419.0 million. A result below that range would contradict the operating support assumed by the recovery case. Company outlook.
• Medium-term appreciation remains measurable. The adjusted-price snapshot dated 2026-09-11 reports a three-month increase of 30.2%. That establishes an earlier advance; it does not establish that the present decline has ended.

Bear Case

• Guidance embeds slower recurring growth. The 2026-08-04 outlook put fiscal 2027 recurring and other revenue at $1.777 billion–$1.792 billion, approximately 8% growth, versus fiscal 2026 growth of 12.2%. A recovery therefore requires valuation support despite the company's projected deceleration. Company outlook.
• Margin comparability changes next year. The 2026-08-04 disclosure extended deferred contract-cost amortization to eight years from seven beginning in fiscal 2027, contributing approximately 120–140 basis points to adjusted earnings before interest, taxes, depreciation and amortization margin. That contribution is an accounting change rather than evidence of faster demand. Company results.
• Planned insider transactions accompanied August strength. August 2026 Forms 4 documented Steven Sarowitz's sales on 2026-08-06 and 2026-08-07 and CFO Glenn Ryan's disposal on 2026-08-19 under previously adopted plans. These establish historical supply; they do not establish discretionary bearish views or continuing September sales.

Setup & Price Structure

The 2026-09-11 adjusted close was $141.66, with a 14-day relative strength index of 30.5 and a reported distance of 17.6% below the 52-week high of $171.93. These are the current measurements. No moving-average value, trading-volume series, short-interest figure or retail-participation measure accompanies that snapshot, so neither distance above a rising average nor crowding can be established.

The $147 shelf described in the 2026-08-30 research is above the latest close. The retained structural invalidation is a weekly close below $140. For grading the recovery case, success requires a weekly close above the market's 2026-08-28 closing level of $157.93 before that invalidation, with the fiscal 2027 recurring-revenue floor still intact; this is a conditional research outcome, not an analyst price target.

Catalyst Calendar (next 30 days)

• 2026-10-02 — September employment report. The Bureau of Labor Statistics schedules the release for this date. It supplies national employment context for Paylocity's per-employee billing model, but cannot establish headcount changes among Paylocity clients. BLS release schedule.
• ~2026-11-04, estimated — First-quarter fiscal 2027 results. This later event tests the recurring-revenue outlook underlying the thesis. The date remains an estimate anchored to the year-earlier release on 2025-11-04, rather than a confirmed company appointment. Year-earlier company release.

Elapsed catalysts

• 2026-09-16 — Federal Reserve policy decision. The Federal Open Market Committee's published calendar confirms the September 15–16 meeting. The decision is relevant to the client-fund interest income Paylocity separately identified in its 2026-08-04 outlook; no direction of the rate decision is assumed. Federal Reserve calendar. (passed 4d ago)

What Would Change Our Mind

Loss of the retained recovery boundary would end the price thesis: a weekly close below $140 is the observable condition. The 2026-09-11 close of $141.66 is above that boundary, although it is below the intermediate $147 shelf. Independently, a reduction of the fiscal 2027 recurring-revenue floor below $1.777 billion, or first-quarter recurring revenue below the $414.0 million guidance floor set on 2026-08-04, would remove the operating support assumed here.

Correlation Notes

This remains a single-name earnings-recovery case. The 2026-09-11 evidence contains no matched return series for Paycom, Paychex or ADP, so it supports no measured peer-correlation claim. Paylocity's separately disclosed client-fund interest income and per-employee billing establish channels of exposure to rates and employment; they do not establish the direction of the shares' response to either scheduled macroeconomic event.